
© 2025 wallstreetONLINE TV
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 880,00 | 881,60 | 14:55 | |
| 880,00 | 881,50 | 14:55 |

| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 14:26 | AstraZeneca relaxed about relaxin drug's poor efficacy in phase 2 heart failure trial | ||
| 14:26 | AstraZeneca CEO hails NHS drug price deal but keeps pause on £200m UK investment | ||
| 13:42 | AstraZeneca rises as cancer drugs power Q4 beat | ||
| 13:30 | Earnings Snapshot: AstraZeneca beats Q4 revenue estimates; initiates FY outlook | ||
| 13:18 | AstraZeneca reports Q4 results |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 11:01 | Could Eli Lilly Turn Today's GLP-1 Obesity Boom Into Multi-Decade, Millionaire-Maker Gains? | ||
| 08:30 | Eli Lilly: Kann der Höhenflug weitergehen? | Eli Lilly bleibt nach den starken Kursanstiegen in einer Phase der Konsolidierung. Entscheidend dürfte nun sein, ob der Kurs die wichtige Unterstützungszone verteidigen kann Den vollständigen Artikel... ► Artikel lesen | |
| 04:17 | JPM Sets INNOVENT BIO's TP at HKD111; Strategic Partnership with Eli Lilly A Positive Surprise | ||
| 04:17 | UBS Envisions INNOVENT BIO's Partnership with Eli Lilly to Provide Upside for Drug Advancement Targets | ||
| 02:10 | Innovent, Lilly ink pact for novel drugs |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 14:06 | EXCLUSIVE: Small Biotech Hoth Therapeutics Claims Experimental Obesity Drug Topped Famed Wegovy In Preclinical Study | ||
| 13:38 | Novo Nordisk A/S - stabile Basis für den nächsten Impuls | ||
| 12:59 | Wegovy maker sues rival over 'knock-off' weight-loss drugs | ||
| 12:55 | Novo Nordisk announces positive results for CagriSema in type 2 diabetes | ||
| 12:34 | Novo Nordisk Rallies 3.6% as Hims & Hers Pulls Compounded Semaglutide |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 10:30 | Stimmungswechsel bei Pfizer: Diese Entwicklung macht misstrauisch | ||
| 10:02 | Volumes soar at Pfizer Ltd counter | ||
| 06:38 | Volumes jump at Pfizer Ltd counter | ||
| Mo | Pfizer verliert an Boden: Experten raten zur Vorsicht | ||
| Mo | Should You Buy Pfizer's Stock for Its 6.3%-Yielding Dividend? |
| Unternehmen / Aktien | Kurs | % |
|---|---|---|
| ASTRAZENECA PLC | 160,70 | 0,00 % |
| ELI LILLY AND COMPANY | 884,00 | +0,82 % |
| NOVO NORDISK A/S | 41,785 | +0,54 % |
| PFIZER INC | 22,730 | +0,15 % |